FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4287510108> ?p ?o ?g. }

• W4287510108 endingPage "2274" @default.
• W4287510108 startingPage "2240" @default.
• W4287510108 abstract "Here we present a protocol for the construction and use of two types of nanocarrier based on bacterial membrane materials for cancer vaccine delivery. Cancer vaccines induce tumor regression through triggering the specific T-cell responses against tumor neoantigens, a process that can be enhanced by nanocarrier delivery. Inspired by the body’s natural immune defenses against bacterial invasion, we have developed two different types of nanocarrier based on bacterial membrane materials, which employ genetically engineered outer-membrane vesicles (OMVs), or hybrid membrane vesicles containing bacterial cytoplasmic membrane, respectively. The OMV-based nanocarriers can rapidly display different tumor antigens through the surface modified Plug-and-Display system, suitable for customized cancer vaccines when the tumor neoantigens can be identified. The hybrid membrane-based nanocarriers are prepared through fusion of the bacterial cytoplasmic membrane and the primary tumor cell membrane from surgically removed tumor tissues, possessing unique advantages as personalized cancer vaccines when the neoantigens are not readily available. Compared with chemically synthesized nanocarriers such as liposomes and polymer without intrinsic adjuvant properties, owing to the large amounts of pathogen-associated molecular patterns, the two nanocarriers can activate the antigen-presenting cells while delivering multiple antigens, thus inducing effective antigen presentation and robust adaptive immune activation. Excluding bacterial culture and tumor tissue collection, the preparation of OMV- and hybrid membrane-based nanocarriers takes ~8 h and 10 h for tumor vaccine construction, respectively. We also detail how to use these nanocarriers to create cancer nanovaccines and evaluate their immunostimulatory and antitumor effects. This protocol details the construction of two types of nanocarrier based on bacterial membrane materials and their use in vaccine delivery to create cancer nanovaccines." @default.
• W4287510108 created "2022-07-25" @default.
• W4287510108 creator A5005586704 @default.
• W4287510108 creator A5007976456 @default.
• W4287510108 creator A5051214456 @default.
• W4287510108 date "2022-07-25" @default.
• W4287510108 modified "2023-10-16" @default.
• W4287510108 title "Nanocarriers based on bacterial membrane materials for cancer vaccine delivery" @default.
• W4287510108 cites W1106966472 @default.
• W4287510108 cites W1858567345 @default.
• W4287510108 cites W1977315768 @default.
• W4287510108 cites W2000735649 @default.
• W4287510108 cites W2006759360 @default.
• W4287510108 cites W2008487520 @default.
• W4287510108 cites W2011458181 @default.
• W4287510108 cites W2050119515 @default.
• W4287510108 cites W2053929414 @default.
• W4287510108 cites W2102906662 @default.
• W4287510108 cites W2127299473 @default.
• W4287510108 cites W2152061559 @default.
• W4287510108 cites W2218656852 @default.
• W4287510108 cites W2263431558 @default.
• W4287510108 cites W2295202170 @default.
• W4287510108 cites W2467200611 @default.
• W4287510108 cites W2519431323 @default.
• W4287510108 cites W2564809671 @default.
• W4287510108 cites W2587048937 @default.
• W4287510108 cites W2606608340 @default.
• W4287510108 cites W2613056214 @default.
• W4287510108 cites W2615521039 @default.
• W4287510108 cites W2724264513 @default.
• W4287510108 cites W2728365508 @default.
• W4287510108 cites W2735393008 @default.
• W4287510108 cites W2761672813 @default.
• W4287510108 cites W2779745123 @default.
• W4287510108 cites W2791931250 @default.
• W4287510108 cites W2797967795 @default.
• W4287510108 cites W2800103955 @default.
• W4287510108 cites W2884027472 @default.
• W4287510108 cites W2904210127 @default.
• W4287510108 cites W2963700080 @default.
• W4287510108 cites W2974995951 @default.
• W4287510108 cites W2982245165 @default.
• W4287510108 cites W2995103612 @default.
• W4287510108 cites W3011710156 @default.
• W4287510108 cites W3012283572 @default.
• W4287510108 cites W3026910902 @default.
• W4287510108 cites W3042574435 @default.
• W4287510108 cites W3082407444 @default.
• W4287510108 cites W3083445928 @default.
• W4287510108 cites W3090478471 @default.
• W4287510108 cites W3096524591 @default.
• W4287510108 cites W3119412259 @default.
• W4287510108 cites W3122472315 @default.
• W4287510108 cites W3124720941 @default.
• W4287510108 cites W3137406939 @default.
• W4287510108 cites W3147873776 @default.
• W4287510108 cites W3148011207 @default.
• W4287510108 cites W3162871690 @default.
• W4287510108 cites W3162963548 @default.
• W4287510108 cites W3181724709 @default.
• W4287510108 cites W3191293859 @default.
• W4287510108 doi "https://doi.org/10.1038/s41596-022-00713-7" @default.
• W4287510108 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35879454" @default.
• W4287510108 hasPublicationYear "2022" @default.
• W4287510108 type Work @default.
• W4287510108 citedByCount "22" @default.
• W4287510108 countsByYear W42875101082022 @default.
• W4287510108 countsByYear W42875101082023 @default.
• W4287510108 crossrefType "journal-article" @default.
• W4287510108 hasAuthorship W4287510108A5005586704 @default.
• W4287510108 hasAuthorship W4287510108A5007976456 @default.
• W4287510108 hasAuthorship W4287510108A5051214456 @default.
• W4287510108 hasBestOaLocation W42875101081 @default.
• W4287510108 hasConcept C121608353 @default.
• W4287510108 hasConcept C147483822 @default.
• W4287510108 hasConcept C171250308 @default.
• W4287510108 hasConcept C18150654 @default.
• W4287510108 hasConcept C185154212 @default.
• W4287510108 hasConcept C185592680 @default.
• W4287510108 hasConcept C192562407 @default.
• W4287510108 hasConcept C203014093 @default.
• W4287510108 hasConcept C2777863537 @default.
• W4287510108 hasConcept C2779820397 @default.
• W4287510108 hasConcept C54355233 @default.
• W4287510108 hasConcept C86803240 @default.
• W4287510108 hasConcept C8891405 @default.
• W4287510108 hasConcept C96232424 @default.
• W4287510108 hasConceptScore W4287510108C121608353 @default.
• W4287510108 hasConceptScore W4287510108C147483822 @default.
• W4287510108 hasConceptScore W4287510108C171250308 @default.
• W4287510108 hasConceptScore W4287510108C18150654 @default.
• W4287510108 hasConceptScore W4287510108C185154212 @default.
• W4287510108 hasConceptScore W4287510108C185592680 @default.
• W4287510108 hasConceptScore W4287510108C192562407 @default.
• W4287510108 hasConceptScore W4287510108C203014093 @default.
• W4287510108 hasConceptScore W4287510108C2777863537 @default.
• W4287510108 hasConceptScore W4287510108C2779820397 @default.

• next